|
2025
|
Invention
|
Crystal form of zipalertinib, and preparation method therefor and use thereof. The present invent... |
|
2024
|
Invention
|
Crystal form of iclepertin, preparation method therefor, and use thereof. The present invention r... |
|
|
Invention
|
Crystal form of zasocitinib, preparation method therefor and use thereof. Provided are a crystal ... |
|
|
Invention
|
Crystal form of nirogacestat dihydrobromide, and preparation method therefor, and use thereof.
P... |
|
|
Invention
|
Crystal form of bezuclastinib, preparation method therefor and use thereof. The present invention... |
|
|
Invention
|
Crystal form of baxdrostat, and preparation method therefor and use thereof. A new crystal form o... |
|
|
Invention
|
Crystal form of resmetirom, and preparation method therefor and use thereof. The present inventio... |
|
|
Invention
|
Crystal form of xevinapant for treating la scchn. The present invention provides novel crystallin... |
|
|
Invention
|
Crystal form of nirogacestat dihydrobromate, and preparation method therefor and use thereof. A n... |
|
|
Invention
|
Crystal form of pirtobrutinib, preparation method therefor and use thereof. The present invention... |
|
|
Invention
|
Co-crystal of aficamten, and preparation method therefor and use thereof. The present invention r... |
|
|
Invention
|
Crystal form of enpatoran, and preparation method therefor and use thereof. The present invention... |
|
2023
|
Invention
|
Crystal form of aprocitentan, preparation method therefor and use thereof. The present invention ... |
|
|
Invention
|
Crystal form of darovasertib, method for preparing same, and use thereof. The present invention r... |
|
|
Invention
|
Co-crystal of elacestrant dihydrochloride, preparation method therefor, and use thereof. The pres... |
|
|
Invention
|
Crystal form of emraclidine, preparation method therefor, and use thereof. The present invention ... |
|
|
Invention
|
Crystal form of xevinapant, method for preparing same and use thereof. The present invention rel... |
|
|
Invention
|
Crystalline form of elacestrant and preparation method and use thereof.
Provided are novel cryst... |
|
|
Invention
|
Crystal form of elacestrant dihydrochloride, preparation method therefor, and use thereof. The pr... |
|
|
Invention
|
Crystal form of blarcamesine hydrochloride, method for preparing same, and use thereof. The prese... |
|
|
Invention
|
Crystal form of nirogacestat dihydrobromide, and preparation method therefor and use thereof. The... |
|
|
Invention
|
Crystal form of tavapadon, and preparation method therefor and use thereof.
A novel crystalline ... |
|
|
Invention
|
Crystal form of tavapadon, and preparation method therefor and use thereof. A new crystal form of... |
|
2022
|
Invention
|
Crystal form of lanifibranor, preparation method therefor, and use thereof. Provided are a crysta... |
|
|
Invention
|
Co-crystal of compound i dihydrochloride and preparation method and use thereof.
Provided are co... |
|
|
Invention
|
Resmetirom crystal, preparation method for same, and uses thereof. Novel crystalline forms of Res... |
|
|
Invention
|
Crystal form of tolebrutinib, preparation method therefor and use thereof. The present invention ... |
|
|
Invention
|
Crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof.
A... |
|
|
Invention
|
Crystal form of hypoxia-inducible factor-prolyl hydroxylase inhibitor.
A novel crystalline form ... |
|
|
Invention
|
Crystal form of upadacitinib, preparation method therefor, and use thereof. Crystalline forms of ... |
|
|
Invention
|
Crystal form of odevixibat, and preparation method and use therefor. Provided are a novel crystal... |
|
2021
|
Invention
|
Crystal form of beumosul mesylate, preparation method for crystal form, and use thereof. The pres... |
|
|
Invention
|
Crystal form of lanifibranor, preparation method therefor, and use thereof. Provided are a new cr... |
|
|
Invention
|
Crystal form of tolebrutinib, preparation method therefor and use thereof. Provided are a crystal... |
|
|
Invention
|
Crystal form of gefapixant citrate, preparation method therefor, and use thereof. Provided are a ... |
|
|
Invention
|
Crystal form of avacopan, preparation method therefor, and use thereof. Provided are a new crysta... |
|
|
Invention
|
Crystal form of risdiplam, preparation method therefor, and use thereof. Provided are a new cryst... |
|
|
Invention
|
Crystal form of resmetirom, preparation method therefor, and use thereof.
The present invention ... |
|
|
Invention
|
Crystal form of resmetirom, preparation method therefor, and use thereof. The present invention r... |
|
|
Invention
|
Crystal form of tafamidis and preparation method therefor and use thereof. The present disclosure... |
|
|
Invention
|
Crystal form of upadacitinib, preparation method therefor, and use thereof. A new crystal form of... |
|
|
Invention
|
Crystal form of upadacitinib, preparation method therefor, and use thereof. Disclosed in the pres... |
|
2020
|
Invention
|
Deucravacitinib crystal form, preparation method therefor and use thereof.
Disclosed are a cryst... |
|
|
Invention
|
Bms-986165 crystal form, preparation method therefor and use thereof.
A crystal form of a compou... |
|
|
Invention
|
Crystalline form csv of bms-986165 hydrochloride, preparation method therefor, and uses thereof. ... |
|
|
Invention
|
Crystal form of tafamidis free acid, preparation method therefor and use thereof. A crystal form ... |
|
|
Invention
|
Upadacitinib crystal form and preparation method therefor and use thereof.
The present disclosur... |
|
2019
|
Invention
|
Crystal form of upadacitinib and preparation method and use thereof.
The present disclosure rela... |
|
|
Invention
|
Cabozantinib malate crystal form, preparation method and use thereof.
The present invention rela... |
|
2018
|
Invention
|
Crystalline forms of gft-505, processes for preparation and use thereof.
The present disclosure ... |
